Prostate Surgery Approach Linked to Lower Survival

A study found the Retzius-sparing prostatectomy method had lower progression-free survival than the anterior approach.

Updated on Oct. 2, 2026 in Men’s Health

Isometric editorial illustration of a multi-jointed robotic surgical arm in a sterile, minimalist environment, representing medical research methodology.
Researchers at the Vattikuti Urology Institute found that the Retzius-sparing robotic prostatectomy method shows lower progression-free survival than the traditional anterior surgical approach. AI Illustration. Upload story photo >

Live Poll

Do you trust newer surgical techniques as much as long-established medical procedures?

Researchers found that the Retzius-sparing robot-assisted radical prostatectomy resulted in worse outcomes compared to the traditional anterior approach for prostate cancer patients. The study tracked 120 men who underwent these procedures at the Vattikuti Urology Institute between 2015 and 2016.

Why it matters

These findings indicate that the choice of surgical technique in robot-assisted prostatectomies significantly impacts long-term survival rates for patients with low- to intermediate-risk prostate cancer.

The Retzius-sparing cohort showed a 25% positive surgical margin rate compared to 13% for the anterior approach. Additionally, 5-year progression-free survival was 80.2% in the Retzius-sparing group versus 91.1% in the anterior group.

The players

Vattikuti Urology Institute

This facility operates under the Henry Ford Health System in Detroit, MI, and serves as a major hub for robotic surgical research and implementation.

The details

Patients were randomly assigned in a 1:1 ratio to receive one of the two surgical approaches. Progression-free survival was defined by investigators as the time from the surgery to either biochemical recurrence or the initiation of salvage or adjuvant treatment.

Timeline

  1. Patients underwent surgery between 2015 and 2016.

  2. Progression-free survival rates were compared at the 5-year mark.

  3. Researchers monitored patients for a median follow-up of 77 months.

  4. The 10-year progression-free survival rates were also compared.

The Big Picture

This study aligns with the Vattikuti Urology Institute's prostate cancer surgical studies by providing long-term outcomes for specific robotic techniques. It follows the established pattern of analyzing surgical outcomes at the institute to refine robotic-assisted techniques.

Patients considering robotic prostatectomy should discuss the comparative long-term outcomes of different surgical approaches with their urological surgeons. This research highlights the importance of asking for surgeon experience and specific technique success rates when evaluating treatment plans.

The takeaway

Choosing the right surgical approach is critical for long-term health outcomes in prostate cancer treatment. Patients should prioritize reviewing data on progression-free survival with their medical teams to make informed decisions.

Further reading

Learn more about advancements and treatment trends at the Men’s Health section.

More information

View the Original clinical trial entry for additional details on the study design.

Source note: This article includes information reported by Oncology Nurse Advisor.

Live Poll

Do you trust newer surgical techniques as much as long-established medical procedures?